Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host- disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: Long-term follow-up of a randomized trial [2]

Blood

Volumn 96, Issue 3, 2000, Pages 1194-1195

  Deeg, H J ^a   Flowers, M E D ^a   Leisenring, W ^a   Appelbaum, F R ^a   Martin, P J ^a   Storb, R F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE;

ADULT; ADVANCED CANCER; BONE MARROW TRANSPLANTATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; LEUKEMIA; LYMPHOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0034254265     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.3.1194a     Document Type: Letter

References (7)

1. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: Methotrexate/prednisone v cyclosporine A/prednisone
2. Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: A randomized double-blind study in patients undergoing allogeneic marrow transplantation
3. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease
4. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: Effect on chronic graft-vs.-host disease and long-term survival
5. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
6. Increased risk of infection in marrow transplant patients given methylprednisolone for graft-versus-host disease prevention
7. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial